What’s in a name?
At INITIO, we know that every great achievement requires the
simple action of beginning, and we’ve drawn our name from this.
The Latin word for “beginning”, initium reflects our commitment to demonstrating initiative, innovation, responsibility, and leadership in molecular medicine.
In its precision, molecular medicine has the potential to expand our understanding of disease and advance diagnosis, prognosis, and treatment.
We’re proud to be part of a new beginning in personalized patient care and population health, supporting the health and health care choices of every individual, both now and into the future.
As western Canada’s only private PET/CT scan facility, INITIO has nearly 20 years of diagnostic scanning experience.
2000 | INITIO attained the 1st PET machine in Canada and the 1st license to produce fluorodeoxyglucose (FDG). |
2010 | INITIO began performing PET/CT oncology (cancer) FDG scans. |
2018 | INITIO provides Alzheimer’s amyloid scans using Amyvid, Neuraceq, and Flutemetamol. INITIO is also actively seeking to provide 68Ga-PSMA imaging for persons with prostate cancer. |

Our Leadership
Geoff Waters
Managing Director
Dr. Philip Cohen
Director
Dr Robert Tarzwell, MD, FRCPC
Chief Medical Officer & Medical Director
The Clinic Team
Dr Rajpaul Attariwala, M.D., PhD, FANM, FRCPC
Nuclear Medicine Radiologist & Biomedical Engineer
Wilson Lo, RTNM, CTIC, BSc
Nuclear Medicine and CT Technologist
The Clinic
Our clinic is welcoming and designed for patient comfort. We encourage accompaniment and support by family members and friends. Focused on individualized patient needs and care; we offer a private, comfortable room in which patients can receive their radiopharmaceutical injection and relax while preparing for their scan.
INITIO is conveniently located near Highway 1 and easily accessible from Exit 29 Willingdon Ave. There is plenty of parking; validation is available.